Effects of non‐viable Lactobacillus reuteri combining with 14‐day standard triple therapy on Helicobacter pylori eradication: A randomized double‐blind placebo‐controlled trial

Effect of probiotics during vonoprazan‐containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial

(2020) Toshihiko Kakiuchi et al.   HELICOBACTER

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

(2020) Viola Andresen et al.   Lancet Gastroenterology & Hepatology

Searching for an optimal therapy for H pylori eradication: High-dose proton-pump inhibitor dual therapy with amoxicillin vs. standard triple therapy for 14 days

(2020) Alex Hwong-Ruey Leow et al.   HELICOBACTER

High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam

(2020) Ngoc Quy Hue Dang et al.   Journal of Global Antimicrobial Resistance

Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial

(2020) Manuel Plomer et al.   Infectious Diseases and Therapy

Efficacy of Potentially Probiotic Fruit-Derived Lactobacillus fermentum, L. paracasei and L. plantarum to Remove Aflatoxin M1 In Vitro

(2020) Paloma Oliveira da Cruz et al.   Toxins

The Effect of Probiotics Supplementation on Gut Microbiota After Helicobacter pylori Eradication: A Multicenter Randomized Controlled Trial

(2020) Bo Tang et al.   Infectious Diseases and Therapy

Short‐term and long‐term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota

(2019) Ping‐I Hsu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

(2019) Jyh-Ming Liou et al.   LANCET INFECTIOUS DISEASES

Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients

(2019) Idan Yelin et al.   NATURE MEDICINE

Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials

(2019) Mingyang Yu et al.   PLoS One

Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study

(2018) D.-S. Liu et al.   CLINICAL MICROBIOLOGY AND INFECTION

Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria

(2018) Ping-I Hsu et al.   HELICOBACTER

Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial

(2018) Adrian G. McNicholl et al.   HELICOBACTER

The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial

(2018) Luyi Chen et al.   EBioMedicine

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

Antibiotics as deep modulators of gut microbiota: between good and evil

(2016) Gianluca Ianiro et al.   GUT

Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients

(2016) Maria P. Dore et al.   MEDICINE

Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials

(2016) Muhan LÜ et al.   PLoS One

Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis

(2016) Chao Lu et al.   Scientific Reports

The Effect of Probiotics on Gut Microbiota during theHelicobacter pyloriEradication: Randomized Controlled Trial

(2015) Bumjo Oh et al.   HELICOBACTER

Probiotics for Standard Triple Helicobacter pylori Eradication

(2015) Goran Hauser et al.   MEDICINE

Probiotics inHelicobacter pylorieradication therapy: A systematic review and meta-analysis

(2015) Min-Min Zhang   WORLD JOURNAL OF GASTROENTEROLOGY

Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis

(2015) ZHIFA LV et al.   Experimental and Therapeutic Medicine

High risk of failing eradication of Helicobacter pylori in patients with diabetes: A meta-analysis

(2014) Chika Horikawa et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis

(2014) Yini Dang et al.   PLoS One

Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study

(2014) Caterina Holz et al.   Probiotics and Antimicrobial Proteins

Faecalibacterium prausnitzii and human intestinal health

(2013) S Miquel et al.   CURRENT OPINION IN MICROBIOLOGY

Fusicatenibacter saccharivorans gen. nov., sp. nov., isolated from human faeces

(2013) T. Takada et al.   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY

Lactobacillus reuteri Strain Combination In Helicobacter pylori Infection

(2013) Ruggiero Francavilla et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Non-Viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a New Approach to Helicobacter pylori Control in Humans

(2013) Heidrun Mehling et al.   Nutrients

Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial

(2013) Mohamed H. Emara et al.   Therapeutic Advances in Gastroenterology

Impact ofLactobacillus reuteriSupplementation on Anti-Helicobacter pyloriLevofloxacin-Based Second-Line Therapy

(2012) Veronica Ojetti et al.   Gastroenterology Research and Practice

The probiotic paradox: live and dead cells are biological response modifiers

(2010) Clifford A. Adams   NUTRITION RESEARCH REVIEWS

Inhibition of Helicobacter pylori Infection in Humans by Lactobacillus reuteri ATCC 55730 and Effect on Eradication Therapy: A Pilot Study

(2008) Ruggiero Francavilla et al.   HELICOBACTER